ARID1B and Alzheimer disease: Thus, ARID1B, a component of SWI/SNF chromatin-remodeling complex, was reportedly a plausible candidate with the transcription upregulated in the temporal lobe in AD subjects [32], presumably because of the allele-specific effects of the rs2281391 variant, which we identified in the ARID1B promoter region (Figure 4a).